COMPOUND OYSTER PEPTIDE 180 mg/1.2g
COMPOUND OYSTER PEPTIDE · CAPSULE · Bispit Canada Ltd.
COMPOUND OYSTER PEPTIDE is a capsule containing compound oyster peptide at 180 mg/1.2g, taken oral. Manufactured by Bispit Canada Ltd..
Key Facts
- Brand Name
- COMPOUND OYSTER PEPTIDE
- Generic Name
- COMPOUND OYSTER PEPTIDE
- NDC Code (Product)
85631-004- Manufacturer
- Bispit Canada Ltd.
- Strength
- 180 mg/1.2g
- Dosage Form
- CAPSULE
- Route
- ORAL
- Marketing Status
- Drug Class
- Non-Standardized Food Allergenic Extract [EPC]
- Marketing Start
- 08/03/2025
Recall History
No Recall HistoryFrequently Asked Questions
What is COMPOUND OYSTER PEPTIDE used for?
COMPOUND OYSTER PEPTIDE contains COMPOUND OYSTER PEPTIDE. It is a capsule taken oral. Consult your doctor for specific uses.
Is COMPOUND OYSTER PEPTIDE a controlled substance?
COMPOUND OYSTER PEPTIDE is not classified as a controlled substance by the DEA.
What is the generic name for COMPOUND OYSTER PEPTIDE?
The generic name for COMPOUND OYSTER PEPTIDE is COMPOUND OYSTER PEPTIDE. There are no other listed brand versions of COMPOUND OYSTER PEPTIDE.
What is the NDC code for COMPOUND OYSTER PEPTIDE 180 mg/1.2g?
The NDC (National Drug Code) for COMPOUND OYSTER PEPTIDE 180 mg/1.2g is 85631-004, listed by Bispit Canada Ltd..
Not medical advice. Always consult your doctor or pharmacist before making any medication decisions.
Data from openFDA · Public domain (CC0 1.0)